These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 21695055)
1. Expression of Fbxo7 in haematopoietic progenitor cells cooperates with p53 loss to promote lymphomagenesis. Lomonosov M; Meziane el K; Ye H; Nelson DE; Randle SJ; Laman H PLoS One; 2011; 6(6):e21165. PubMed ID: 21695055 [TBL] [Abstract][Full Text] [Related]
2. Knockdown of Fbxo7 reveals its regulatory role in proliferation and differentiation of haematopoietic precursor cells. Meziane el K; Randle SJ; Nelson DE; Lomonosov M; Laman H J Cell Sci; 2011 Jul; 124(Pt 13):2175-86. PubMed ID: 21652635 [TBL] [Abstract][Full Text] [Related]
3. Transforming activity of Fbxo7 is mediated specifically through regulation of cyclin D/cdk6. Laman H; Funes JM; Ye H; Henderson S; Galinanes-Garcia L; Hara E; Knowles P; McDonald N; Boshoff C EMBO J; 2005 Sep; 24(17):3104-16. PubMed ID: 16096642 [TBL] [Abstract][Full Text] [Related]
4. Opposing effects on the cell cycle of T lymphocytes by Fbxo7 via Cdk6 and p27. Patel SP; Randle SJ; Gibbs S; Cooke A; Laman H Cell Mol Life Sci; 2017 Apr; 74(8):1553-1566. PubMed ID: 27915416 [TBL] [Abstract][Full Text] [Related]
5. Deletion of Irf5 protects hematopoietic stem cells from DNA damage-induced apoptosis and suppresses γ-irradiation-induced thymic lymphomagenesis. Bi X; Feng D; Korczeniewska J; Alper N; Hu G; Barnes BJ Oncogene; 2014 Jun; 33(25):3288-97. PubMed ID: 23912454 [TBL] [Abstract][Full Text] [Related]
7. Fbxo7 promotes Cdk6 activity to inhibit PFKP and glycolysis in T cells. Harris R; Yang M; Schmidt C; Royet C; Singh S; Natarajan A; Morris M; Frezza C; Laman H J Cell Biol; 2022 Jul; 221(7):. PubMed ID: 35670764 [TBL] [Abstract][Full Text] [Related]
8. Expansion of the hematopoietic stem cell compartment is necessary but not sufficient for gain-of-function mutant p53 R248Q to accelerate lymphomagenesis. Yallowitz AR; Hanel W; Moll UM Cell Death Differ; 2015 Aug; 22(8):1397. PubMed ID: 26045050 [No Abstract] [Full Text] [Related]
10. TGFBI Expressed by Bone Marrow Niche Cells and Hematopoietic Stem and Progenitor Cells Regulates Hematopoiesis. Klamer SE; Dorland YL; Kleijer M; Geerts D; Lento WE; van der Schoot CE; von Lindern M; Voermans C Stem Cells Dev; 2018 Nov; 27(21):1494-1506. PubMed ID: 30084753 [TBL] [Abstract][Full Text] [Related]
11. Repression of p53-target gene Bbc3/PUMA by MYSM1 is essential for the survival of hematopoietic multipotent progenitors and contributes to stem cell maintenance. Belle JI; Petrov JC; Langlais D; Robert F; Cencic R; Shen S; Pelletier J; Gros P; Nijnik A Cell Death Differ; 2016 May; 23(5):759-75. PubMed ID: 26768662 [TBL] [Abstract][Full Text] [Related]
12. Oncogenic Vav1 induces Rac-dependent apoptosis via inhibition of Bcl-2 family proteins and collaborates with p53 deficiency to promote hematopoietic progenitor cell proliferation. Gu Y; Siefring JE; Wang L; Chae HD; Bailey JR; Zheng Y Oncogene; 2006 Jun; 25(28):3963-72. PubMed ID: 16474842 [TBL] [Abstract][Full Text] [Related]
13. p53 deficiency increases transformation by v-Abl and rescues the ability of a C-terminally truncated v-Abl mutant to induce pre-B lymphoma in vivo. Zou X; Cong F; Coutts M; Cattoretti G; Goff SP; Calame K Mol Cell Biol; 2000 Jan; 20(2):628-33. PubMed ID: 10611241 [TBL] [Abstract][Full Text] [Related]
14. Oligonucleotide enhanced cytotoxicity of Idarubicin for lymphoma cells. Sharp JG; Bishop MR; Copple B; Greiner TC; Iversen PL; Jackson JD; Joshi SS; Benner EJ; Mann SL; Rao AK; Vose JM Leuk Lymphoma; 2001 Jul; 42(3):417-27. PubMed ID: 11699407 [TBL] [Abstract][Full Text] [Related]
15. Necdin, a p53 target gene, regulates the quiescence and response to genotoxic stress of hematopoietic stem/progenitor cells. Asai T; Liu Y; Di Giandomenico S; Bae N; Ndiaye-Lobry D; Deblasio A; Menendez S; Antipin Y; Reva B; Wevrick R; Nimer SD Blood; 2012 Aug; 120(8):1601-12. PubMed ID: 22776820 [TBL] [Abstract][Full Text] [Related]
16. Loss of nuclear activity of the FBXO7 protein in patients with parkinsonian-pyramidal syndrome (PARK15). Zhao T; De Graaff E; Breedveld GJ; Loda A; Severijnen LA; Wouters CH; Verheijen FW; Dekker MC; Montagna P; Willemsen R; Oostra BA; Bonifati V PLoS One; 2011 Feb; 6(2):e16983. PubMed ID: 21347293 [TBL] [Abstract][Full Text] [Related]
17. Conditional inactivation of Fbxw7 impairs cell-cycle exit during T cell differentiation and results in lymphomatogenesis. Onoyama I; Tsunematsu R; Matsumoto A; Kimura T; de Alborán IM; Nakayama K; Nakayama KI J Exp Med; 2007 Nov; 204(12):2875-88. PubMed ID: 17984302 [TBL] [Abstract][Full Text] [Related]
18. Defective erythropoiesis in a mouse model of reduced Fbxo7 expression due to decreased p27 expression. Randle SJ; Nelson DE; Patel SP; Laman H J Pathol; 2015 Oct; 237(2):263-72. PubMed ID: 26095538 [TBL] [Abstract][Full Text] [Related]
19. Cdk2 and Cdk4 activities are dispensable for tumorigenesis caused by the loss of p53. Padmakumar VC; Aleem E; Berthet C; Hilton MB; Kaldis P Mol Cell Biol; 2009 May; 29(10):2582-93. PubMed ID: 19307310 [TBL] [Abstract][Full Text] [Related]
20. The reduction of in vitro radiation-induced Fas-related apoptosis in CD34+ progenitor cells by SCF, FLT-3 ligand, TPO, and IL-3 in combination resulted in CD34+ cell proliferation and differentiation. Drouet M; Mathieu J; Grenier N; Multon E; Sotto JJ; Herodin F Stem Cells; 1999; 17(5):273-85. PubMed ID: 10527462 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]